1
|
OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.
|
Brain
|
2007
|
3.35
|
2
|
Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance.
|
Brain
|
2007
|
3.14
|
3
|
Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism.
|
Biochim Biophys Acta
|
2010
|
1.79
|
4
|
Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations.
|
Hum Mutat
|
2009
|
1.67
|
5
|
Heterozygous OPA1 mutations in Behr syndrome.
|
Brain
|
2010
|
1.57
|
6
|
eOPA1: an online database for OPA1 mutations.
|
Hum Mutat
|
2005
|
1.43
|
7
|
OPA1-associated disorders: phenotypes and pathophysiology.
|
Int J Biochem Cell Biol
|
2009
|
1.40
|
8
|
Mitochondrial dynamics and disease, OPA1.
|
Biochim Biophys Acta
|
2006
|
1.35
|
9
|
Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors.
|
J Clin Endocrinol Metab
|
2004
|
1.35
|
10
|
Hereditary optic neuropathies share a common mitochondrial coupling defect.
|
Ann Neurol
|
2008
|
1.33
|
11
|
Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis.
|
J Cell Physiol
|
2007
|
1.30
|
12
|
Structure and chromosomal distribution of human mitochondrial pseudogenes.
|
Genomics
|
2002
|
1.27
|
13
|
OPA1 functions in mitochondria and dysfunctions in optic nerve.
|
Int J Biochem Cell Biol
|
2009
|
1.19
|
14
|
Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors.
|
J Clin Endocrinol Metab
|
2004
|
1.19
|
15
|
OPA1 R445H mutation in optic atrophy associated with sensorineural deafness.
|
Ann Neurol
|
2005
|
1.18
|
16
|
OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution.
|
Genome Res
|
2010
|
1.17
|
17
|
Leigh-like encephalopathy complicating Leber's hereditary optic neuropathy.
|
Ann Neurol
|
2002
|
1.14
|
18
|
PGC-1-related coactivator and targets are upregulated in thyroid oncocytoma.
|
Biochem Biophys Res Commun
|
2003
|
1.14
|
19
|
Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease.
|
Ann Neurol
|
2007
|
1.13
|
20
|
Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutations.
|
Exp Neurol
|
2010
|
1.12
|
21
|
Dominant optic atrophy.
|
Orphanet J Rare Dis
|
2012
|
1.11
|
22
|
Whole mitochondrial genome screening in maternally inherited non-syndromic hearing impairment using a microarray resequencing mitochondrial DNA chip.
|
Eur J Hum Genet
|
2007
|
1.10
|
23
|
Maternal smoking is associated with mitochondrial DNA depletion and respiratory chain complex III deficiency in placenta.
|
Am J Physiol Endocrinol Metab
|
2005
|
1.03
|
24
|
The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse.
|
Brain
|
2012
|
1.03
|
25
|
Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy.
|
Hum Mutat
|
2003
|
0.99
|
26
|
Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells.
|
J Biol Chem
|
2013
|
0.98
|
27
|
Low serum testosterone assayed by liquid chromatography-tandem mass spectrometry. Comparison with five immunoassay techniques.
|
Clin Chim Acta
|
2007
|
0.97
|
28
|
Mitochondrial DNA in the oocyte and the developing embryo.
|
Curr Top Dev Biol
|
2007
|
0.97
|
29
|
Rare primary mitochondrial DNA mutations and probable synergistic variants in Leber's hereditary optic neuropathy.
|
PLoS One
|
2012
|
0.96
|
30
|
Comparison of spheroids formed by rat glioma stem cells and neural stem cells reveals differences in glucose metabolism and promising therapeutic applications.
|
J Biol Chem
|
2012
|
0.96
|
31
|
Increase of mitochondrial DNA content and transcripts in early bovine embryogenesis associated with upregulation of mtTFA and NRF1 transcription factors.
|
Reprod Biol Endocrinol
|
2005
|
0.94
|
32
|
Reversible optic neuropathy with OPA1 exon 5b mutation.
|
Ann Neurol
|
2008
|
0.93
|
33
|
Experimental determination of organelle targeting-peptide cleavage sites using transient expression of green fluorescent protein translational fusions.
|
Anal Biochem
|
2012
|
0.92
|
34
|
Papilloedema and MRI enhancement of the prechiasmal optic nerve at the acute stage of Leber hereditary optic neuropathy.
|
J Neurol Neurosurg Psychiatry
|
2010
|
0.91
|
35
|
Gene profiling reveals specific oncogenic mechanisms and signaling pathways in oncocytic and papillary thyroid carcinoma.
|
Oncogene
|
2005
|
0.91
|
36
|
The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene.
|
Am J Ophthalmol
|
2003
|
0.90
|
37
|
Bioenergetic defect associated with mKATP channel opening in a mouse model carrying a mitofusin 2 mutation.
|
FASEB J
|
2011
|
0.89
|
38
|
Diagnosis of myotubular myopathy in the oldest known manifesting female carrier: a clinical and genetic study.
|
Neuromuscul Disord
|
2007
|
0.89
|
39
|
Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K).
|
Neurogenetics
|
2008
|
0.89
|
40
|
Genetically determined optic neuropathies.
|
Curr Opin Neurol
|
2010
|
0.89
|
41
|
Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.
|
Biochim Biophys Acta
|
2012
|
0.89
|
42
|
Mitochondrial bioenergetic background confers a survival advantage to HepG2 cells in response to chemotherapy.
|
Mol Carcinog
|
2009
|
0.89
|
43
|
Hereditary spastic paraplegia-like disorder due to a mitochondrial ATP6 gene point mutation.
|
Mitochondrion
|
2010
|
0.88
|
44
|
Prevalence of rare mitochondrial DNA mutations in mitochondrial disorders.
|
J Med Genet
|
2013
|
0.87
|
45
|
MFN2, a new gene responsible for mitochondrial DNA depletion.
|
Brain
|
2012
|
0.87
|
46
|
Relative frequencies of inherited retinal dystrophies and optic neuropathies in Southern France: assessment of 21-year data management.
|
Ophthalmic Epidemiol
|
2013
|
0.86
|
47
|
Molecular characterization of corona radiata cells from patients with diminished ovarian reserve using microarray and microfluidic-based gene expression profiling.
|
Hum Reprod
|
2012
|
0.86
|
48
|
Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data.
|
Hum Mutat
|
2014
|
0.85
|
49
|
A locus-specific database for mutations in GDAP1 allows analysis of genotype-phenotype correlations in Charcot-Marie-Tooth diseases type 4A and 2K.
|
Orphanet J Rare Dis
|
2011
|
0.85
|
50
|
Standardized mitochondrial analysis gives new insights into mitochondrial dynamics and OPA1 function.
|
Int J Biochem Cell Biol
|
2012
|
0.84
|
51
|
Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot-Marie-Tooth type 2A disease.
|
Neurogenetics
|
2009
|
0.84
|
52
|
Sensorineural hearing loss in OPA1-linked disorders.
|
Brain
|
2013
|
0.84
|
53
|
New evidence of a mitochondrial genetic background paradox: impact of the J haplogroup on the A3243G mutation.
|
BMC Med Genet
|
2008
|
0.82
|
54
|
Acute and late-onset optic atrophy due to a novel OPA1 mutation leading to a mitochondrial coupling defect.
|
Mol Vis
|
2009
|
0.82
|
55
|
Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration.
|
BMC Res Notes
|
2011
|
0.82
|
56
|
Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity.
|
Mitochondrion
|
2009
|
0.81
|
57
|
Never too old to harbour a young man's disease?
|
Br J Ophthalmol
|
2011
|
0.81
|
58
|
A novel mutation in the mitochondrial tRNA Asn gene associated with a lethal disease.
|
Biochem Biophys Res Commun
|
2005
|
0.81
|
59
|
Early compaction at day 3 may be a useful additional criterion for embryo transfer.
|
J Assist Reprod Genet
|
2013
|
0.79
|
60
|
Decreased expression of thyrotropin receptor gene suggests a high-risk subgroup for oncocytic adenoma.
|
Eur J Endocrinol
|
2004
|
0.79
|
61
|
Oxygen consumption and expression of the adenine nucleotide translocator in cells lacking mitochondrial DNA.
|
Exp Cell Res
|
2002
|
0.79
|
62
|
OPA1-related dominant optic atrophy is not strongly influenced by mitochondrial DNA background.
|
BMC Med Genet
|
2009
|
0.78
|
63
|
[Mitochondria and reproduction].
|
Med Sci (Paris)
|
2004
|
0.78
|
64
|
[Neurotoxicity of pesticides: its relationship with neurodegenerative diseases].
|
Med Sci (Paris)
|
2013
|
0.77
|
65
|
mtDNA controls expression of the Death Associated Protein 3.
|
Exp Cell Res
|
2006
|
0.77
|
66
|
Cataract as a phenotypic marker for a mutation in WFS1, the Wolfram syndrome gene.
|
Eur J Ophthalmol
|
2012
|
0.76
|
67
|
Are zona pellucida genes involved in recurrent oocyte lysis observed during in vitro fertilization?
|
J Assist Reprod Genet
|
2013
|
0.75
|
68
|
Is ABCC6 a genuine mitochondrial protein?
|
BMC Res Notes
|
2013
|
0.75
|
69
|
[From yeast to neurodegenerative diseases: ten years of exploration of mitochondrial dynamic disorders].
|
Med Sci (Paris)
|
2010
|
0.75
|
70
|
Mitochondrial diseases preferentially involve proteins with prokaryote homologues.
|
C R Biol
|
2004
|
0.75
|